Rx drug information, pharmaceutical research, clinical trials, news, and more
Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: a randomized study in healthy subjects. [2013]
Use of canakinumab in the cryopyrin-associated periodic syndrome. [2009]
Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. [2012]
Neurologic manifestations of the cryopyrin-associated periodic syndrome. [2010]
Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons. [2013]
All Rights reserved - Copyright DrugLib.com, 2006-2017